Nitrofurantoin Dosing in Pregnancy
For pregnant women with uncomplicated UTI and less than 36 weeks gestation, nitrofurantoin should be dosed at 100 mg orally four times daily (every 6 hours) for 7 days. 1
Dosing Regimen
The evidence-based dosing for nitrofurantoin in pregnancy is:
- Dose: 100 mg orally every 6 hours (four times daily)
- Duration: 7 days minimum, or at least 3 days after obtaining sterile urine 1
- Maximum daily dose: 400 mg/day (100 mg per dose) 1
This recommendation comes from 2022 guidelines on multidrug-resistant organisms that specifically address pediatric and pregnancy dosing 1. The four-times-daily dosing (every 6 hours) is explicitly stated for uncomplicated UTI treatment 1.
Critical Evidence on Duration
A 1-day regimen is significantly inferior to 7-day treatment in pregnancy. A large randomized controlled trial of 778 pregnant women with asymptomatic bacteriuria demonstrated bacteriologic cure rates of only 75.7% with 1-day treatment versus 86.2% with 7-day treatment (cure rate difference -10.5%, 95% CI -16.1% to -4.9%) 2. Importantly, the 1-day regimen group had significantly lower mean birth weight and gestational age at delivery 2.
Important Safety Considerations
Gestational Age Restrictions
- Contraindicated at term (≥36 weeks gestation): Risk of hemolytic anemia in the newborn due to immature erythrocyte enzyme systems 3
- Safe before 36 weeks: The question specifically addresses patients <36 weeks gestation, where nitrofurantoin is appropriate
Monitoring Requirements
- Ensure normal renal function (creatinine clearance >60 mL/min) before prescribing, as renal impairment increases risk of peripheral neuropathy 3
- Nitrofurantoin should only be used for uncomplicated lower UTI (cystitis), not for pyelonephritis or perinephric abscess 1
Common Pitfalls to Avoid
- Do not use single-dose or 3-day regimens in pregnancy - these are inadequate based on RCT evidence showing inferior outcomes 2
- Do not prescribe at or after 36 weeks gestation - switch to alternative agents like beta-lactams
- Do not use for upper tract infections - nitrofurantoin achieves inadequate tissue concentrations for pyelonephritis 4
- Avoid in patients with G6PD deficiency - risk of hemolytic anemia 3
Alternative Considerations
While fosfomycin 3g single dose has been studied in pregnancy, meta-analysis shows no significant difference in cure rates compared to nitrofurantoin, though fosfomycin had slightly more adverse events 5. The 7-day nitrofurantoin regimen remains the evidence-based standard for pregnant women with uncomplicated UTI.